Volume 95, Issue 2, Pages 406-409 (February 1989) Continuous Monitoring of Mixed Venous Oxygen Saturation as an Indicator of Pharmacologic Intervention Erkan Hassan, Pharm.D., Jeffery A. Green, Pharm.D., Andrew R. Nara, M.D., F.C.C.P., Robert C. Jarvis, M.D., Richard J. Kasmer, Pharm.D., Robert Pospisil, R.N. CHEST Volume 95, Issue 2, Pages 406-409 (February 1989) DOI: 10.1378/chest.95.2.406 Copyright © 1989 The American College of Chest Physicians Terms and Conditions
FIGURE 1 Fenoldopam time response curves for CI and SvO2. Mean ± SD for all eight patients. Asterisk is p<0.05 compared to baseline. CHEST 1989 95, 406-409DOI: (10.1378/chest.95.2.406) Copyright © 1989 The American College of Chest Physicians Terms and Conditions
FIGURE 2 Overall data and linear regression between SvO, and CI responses to fenoldopam. CHEST 1989 95, 406-409DOI: (10.1378/chest.95.2.406) Copyright © 1989 The American College of Chest Physicians Terms and Conditions
FIGURE 3 Individual data, linear regression, and correlation coefficient between mixed venous oxygen saturation (SvO2 %, x axis) and cardiac index (CI L/min/m2, y axis). CHEST 1989 95, 406-409DOI: (10.1378/chest.95.2.406) Copyright © 1989 The American College of Chest Physicians Terms and Conditions